Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc. Warrant

0.0051
0.0000
Volume:- -
Turnover:- -
Market Cap:1.11M
PE:-0.01
High:0.0051
Open:0.0051
Low:0.0051
Close:0.0051
52wk High:0.6525
52wk Low:0.0040
Shares:218.39M
Float Shares:- -
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5048
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Nuvation Bio, Inc. Warrant
Exchange:
NYSE
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung , M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco .